Abstract:Fibrocytes are myeloid lineage cells implicated in wound healing, repair, and fibrosis. We previously showed that fibrocytes are mobilized into the circulation after vascular injury, including the immune-mediated injury that occurs after allogeneic transplantation. A common response to inflammatory vascular injury is intimal hyperplasia ( IH), which, alongside vascular remodeling, results in progressive loss of blood flow, downstream ischemia, and end-organ fibrosis. This forms the pathological basis of transplant arteriosclerosis and other diseases including post-angioplasty re-stenosis. In investigating whether fibrocytes contribute to IH, we previously showed that subpopulations expressing smooth muscle actin and CD31 are recruited to the site of injury and accumulate in the neointima. Expression of tissue factor (TF) by these "CD31+ myofibrocytes" is needed for progressive neointimal expansion, such that TF inhibition limits the neointima to a single layer of cells by day 28 post-injury. The aim of this study was to determine pathophysiological mediators downstream of TF that contribute to myofibrocyte-orchestrated IH. We first show that myofibrocytes make up a significant component of the neointima 28 days following injury. Using a previously defined adoptive transfer model, we then show that CD31+ myofibrocytes get recruited early to the site of injury; this model allows manipulations of the adoptively transferred cells to study how IH develops. Having confirmed that inhibition of TF on adoptively transferred cells prevents IH, we then show that TF, primarily through the generation of thrombin, induces secretion of angiopoietin-2 by myofibrocytes and this directly stimulates proliferation, inhibits apop tosis, and induces CXCL-12 production by neointimal cells, including non-fibrocytes, all of which promote progressive IH in vivo. Prior incubation to inhibit angiopoietin-2 secretion by or block TIE-2 signaling on adoptively transferred fibrocytes inhibits IH. These novel data indicate that angiopoietin-2 production by early recruited myofibrocytes critically influences the development of IH after vascular injury and suggest new therapeutic avenues for exploration.

Toll-like Receptor 2 in Promoting Angiogenesis after Acute Ischemic Injury.

Endothelial-Specific Expression of Mitochondrial Thioredoxin Promotes Ischemia-Mediated Arteriogenesis and Angiogenesis

Heme Oxygenase-1 in Macrophages Impairs the Perfusion Recovery after Hindlimb Ischemia by Suppressing Autolysosome-Dependent Degradation of NLRP3.

Annexin A2 Promotes Angiogenesis after Ischemic Stroke Via Annexin A2 Receptor – AKT/ERK Pathways

Dual Roles of Tumor Necrosis Factor-Α Receptor-1 in a Mouse Model of Hindlimb Ischemia

The protective effects of tumor necrosis factor receptor 1 deletion on hindlimb ischemia

Angiogenesis Mediated by Toll-Like Receptor 4 in Ischemic Neural Tissue

Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors

Angiopoietin-2 promotes inflammatory lymph angiogenesis and its effect can be blocked by the specific inhibitor L1-10

Therapeutic progenitor cell application for tissue regeneration: Analyzing the impact of toll-like receptor signaling on c-kit+ cell migration following ischemia-reperfusion injury in vivo

Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia

Tollip Negatively Regulates Vascular Smooth Muscle Cell–Mediated Neointima Formation by Suppressing Akt‐Dependent Signaling

TLR2 promotes traumatic deep venous thrombosis of the lower extremity following femoral fracture by activating the NF‑κB/COX‑2 signaling pathway in rats

Neointimal Hyperplasia after Endoluminal Injury in Mice is Dependent on Tissue Factor- and Angiopoietin-2 Dependent Interferon Gamma Production by Fibrocytes and Macrophages

Activation of Toll-like receptor 2 promotes mesenchymal stem/stromal cell-mediated immunoregulation and angiostasis through AKR1C1

TLR2 Ligands Induce Cardioprotection Against Ischaemia/reperfusion Injury Through a PI3K/Akt-dependent Mechanism.

Inhibition of Angiopoietin-2 Production by Myofibrocytes Inhibits Neointimal Hyperplasia after Endoluminal Injury in Mice

Neuroprotective Effect of Angiopoietin2 Is Associated with Angiogenesis in Mouse Brain Following Ischemic Stroke

C1q/TNF-related Protein-2 Improved Angiogenesis to Protect Myocardial Function During Ischaemia‒reperfusion.

The mechanism of TLR2 activation and lung injury during the process of total hepatic ischemia/reperfusion in mice

TLR2 Mrna Upregulation in Ischemic Lobes in Mouse Partial Hepatic Ischemia/reperfusion Injury Model